Publication: Efficacy and safety of long-term mycophenolate sodium therapy in pemphigus vulgaris
Date
Authors
Başkan, Emel Bülbül
Yılmaz, Mediha
Tunalı, Şükran
Sarıcaoğlu, Hayriye
Authors
Advisor
Language
Type
Publisher:
Wiley
Journal Title
Journal ISSN
Volume Title
Abstract
Background
Pemphigus is a chronic immunobullous disease, characterized by formation of blisters and erosions in skin and/or mucous membranes. This severe disease requires systemic immunosuppressive therapy. However, some patients are refractory, and long-term use of immunosuppressive agents can cause serious side-effects. Mycophenolic acid is increasingly being used as a corticosteroid-sparing agent or as monotherapy in immunosuppressive regimens.
Objectives
We aimed to evaluate the effectiveness of mycophenolate sodium, a sodium salt of mycophenolic acid, in the treatment of pemphigus vulgaris.
Methods
Six patients who were diagnosed as pemphigus vulgaris with active, refractory disease were treated with mycophenolate sodium. Three patients received mycophenolate sodium monotherapy; three patients received mycophenolate in combination with steroid. All patients were monitored regularly.
Results
Mycophenolate sodium was well tolerated with a similar efficacy of mycophenolate mofetil, and no side-effects have been observed.
Conclusions
Mycophenolate sodium appears to be an effective and safe alternative in the treatment of pemphigus vulgaris.
Description
Source:
Keywords:
Keywords
Mycophenolate sodium, Pemphigus, Therapy, Mofetil, Dermatology
Citation
Başkan, E. B. vd. (2009). "Efficacy and safety of long-term mycophenolate sodium therapy in pemphigus vulgaris". Journal of the European Academy of Dermatology and Venereology, 23(12), 1432-1434.